Cystic Fibrosis Related Diabetes: The Changing Clinical Landscape
Cystic fibrosis (CF) was first described almost 80 years ago and was once considered a fatal childhood disease. Today, thanks to major advances in clinical...
Current Edition: ADE September Edition 2025
SGLT2 inhibitors – Sick day management and facility transition
Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are a novel drug class that was first approved in Australia for managing diabetes in 2012.1 Since then,...
Artificial Intelligence tools to support diabetes educators in practice
Diabetes educators face increasing demands as they balance clinical care, administrative responsibilities, and client education. The increasing diabetes...
ATIC: A Collaborative Effort to Change the Treatment Paradigm for Type 1 Diabetes
For more than 100 years, insulin has been the sole treatment for type 1 diabetes (T1D). Improvements in glucose sensing and insulin delivery technology...
Research methods: Randomised Controlled Trials (RCTs)
This article follows on from my previous article in the June 2025 ADE covering levels of evidence and different methods in quantitative research. ...
Stay on the right side of Ahpra’s advertising requirements
While there are laws for advertising any business in Australia, The Australian Health Practitioner Regulation Agency (Ahpra) has specific requirements for...
An eLearning module to address insulin errors in the workplace
In 2014, the Australian Commission on Safety and Quality in Health Care launched an eLearning module focused on minimising insulin errors in healthcare...
Positive ageing for people living with diabetes
Australians are living longer, and this is something to celebrate. Currently, approximately 17% of the Australian population is aged 65 years or...